-Sialidase and cruzipain are important virulence factors from , the etiological agent of Chagas disease, that have highly antigenic domains in their structure and were reported as potential tools for diagnosis of the illness. The aim of the present study is to assess the possibility of using cruzipain and the catalytic domain of -sialidase in a Surface Plasmon Resonance-based immunosensor for the diagnosis of chronic Chagas disease. Immunoassays carried out with canine sera verified that cruzipain allows the detection of anti- antibodies whereas recombinant -sialidase did not yield specific detections, due to the high dilutions of serum used in the immunoassays that hinder the possibility to sense the specific low titer antibodies. The developed cruzipain-based biosensor, whose price per assay is comparable to a commercial enzyme-linked immunosorbent assay (ELISA), was successfully applied for the rapid quantification of specific antibodies against in fresh human sera showing an excellent agreement with ELISA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acsinfecdis.9b00269 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!